跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,468 条关于
“HER2+”
全部
5,468
临床试验
3,803
药物
327
机构
8
资讯
1,330
去年
HER2DX® Genomic Assay Transforms Treatment Decisions in Early-Stage HER2+ Breast Cancer
去年
IBI354 Demonstrates Promising Efficacy and Tolerability in HER2-Positive and HER2-Low Breast Cancer
去年
3D Pathology Technology Reclassifies 67% of HER2-Null Breast Cancer Cases as HER2-Expressing
去年
Trastuzumab Deruxtecan Shows Promise in HER2-Overexpressing NSCLC
去年
HER2-Targeted Therapies Solidify Role in Early-Stage HER2-Positive Breast Cancer Treatment
9个月前
REVEAL GENOMICS Unveils Breakthrough CNS Progression Score for HER2+ Breast Cancer Brain Metastasis Prediction at SABCS 2025
3个月前
HER2-LADDER: A Spatially Interpretable AI Framework Predicts Neoadjuvant Dual HER2-Targeted Therapy Response in Breast Cancer
7个月前
Innovent Initiates Phase 3 Trial of IBI354 HER2 ADC for First-Line HER2-Positive Breast Cancer Treatment
3个月前
Soluble HER2 Drives CD8⁺ T-Cell Exhaustion and Limits Immunotherapy Response in HER2-Low Triple-Negative Breast Cancer
去年
FDA Approves Roche's Companion Diagnostic for HER2-Ultralow Metastatic Breast Cancer
第 1 页,共 133 页
上一页
下一页